Colibacillosis is a common and economically significant bacterial infection in birds caused by pathogenic strains of Escherichia coli, commonly known as E. coli. While E. coli is a normal inhabitant of the avian intestinal tract, certain pathogenic strains classified as avian pathogenic E. coli or APEC can cause serious disease affecting multiple organ systems. This condition occurs worldwide and affects virtually all bird species, from companion parrots and canaries to commercial poultry and wild birds. Colibacillosis ranks among the most important bacterial diseases in avian medicine due to its prevalence, economic impact, and potential severity.
Avian pathogenic E. coli strains possess specific virulence factors that enable them to cause disease, distinguishing them from the harmless commensal strains normally present in the gut. These virulence factors include adhesins that allow attachment to tissues, iron acquisition systems, toxins, and mechanisms to evade host immune defenses. Birds become infected through inhalation of contaminated dust and aerosols, ingestion of contaminated food or water, or through the navel in newly hatched chicks. The respiratory route is particularly important, with inhaled bacteria establishing infection in the air sacs and spreading to other organs through the bloodstream.
The impact of colibacillosis on affected birds ranges from localized infections to overwhelming septicemia depending on the pathogen's virulence, the dose of exposure, and the bird's immune status. Common manifestations include airsacculitis affecting the respiratory system, perihepatitis and pericarditis as bacteria spread to abdominal organs and the heart, and septicemia with involvement of multiple organ systems. Young birds are particularly vulnerable, with yolk sac infections representing a major cause of mortality in chicks. The condition causes significant losses in commercial poultry through mortality, decreased growth rates, and condemnation of carcasses at processing.
Treatment of colibacillosis requires appropriate antibiotic therapy selected based on sensitivity testing, as antibiotic resistance is common among E. coli strains. Early intervention combined with supportive care improves outcomes, though prevention through proper husbandry and biosecurity remains preferable to treating established disease. Working with a qualified avian veterinarian ensures accurate diagnosis and selection of effective antibiotics. Understanding the predisposing factors that allow E. coli to cause disease enables implementation of preventive measures that reduce incidence and severity of this important avian condition.
